Search This Blog

Wednesday, August 7, 2019

Catalyst Pharmaceuticals EPS beats by $0.07, beats on revenue

Catalyst Pharmaceuticals (NASDAQ:CPRX): Q2 GAAP EPS of $0.10 beats by $0.07.
Revenue of $28.84M beats by $10.85M.
Shares +9.16%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)